HAL vs IMDX · P/E 9.3, $19.05B cap vs rev $1.9M
Halliburton Company (HAL) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported IMDX revenue for 2024-12-31 was $1.9M. Net income was -$60.7M. Revenue was up 25.1% from 2023-12-31 to 2024-12-31. IMDX currently screens at market cap $0.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IMDX currently screens at market cap $0.
Not investment advice. Open the HAL and IMDX stock pages for the full models.
Not investment advice.